Vodobatinib
Bcr-Abl1 inhibitor
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Bcr-Abl1 inhibitor
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Discription | Vodobatinib, also known as K-0706, is a novel 3rd generation (3G) TKI effective against wild-type and mutated BCR-ABL1 with limited off-target activity. |
---|
Catalog Num | A22504 |
---|---|
Formula | C27H20ClN3O2 |
Molecular Weight | 453.926 |
CAS Number | 1388803-90-4 |
SMILES | CC1=C(C=C(C(NNC(C2=C(Cl)C=CC=C2C)=O)=O)C=C1)C#CC(C=N3)=CC4=C3C=CC=C4 |
Synonyms | Vodobatinib, K-0706, K0706, K0706, |
Storage | Store lyophilized at -20ºC, keep desiccated. |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2